{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:37:07Z","timestamp":1768264627989,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":4912,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1538-7836.2009.03411.x","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T07:24:21Z","timestamp":1247469861000},"page":"61-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"S1","title":["Mouse models of von Willebrand disease"],"prefix":"10.1016","volume":"7","author":[{"given":"R.","family":"PENDU","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.D.","family":"CHRISTOPHE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.V.","family":"DENIS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.med.56.082103.104713","article-title":"New concepts in von Willebrand disease","volume":"56","author":"Sadler","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0015","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/j.1538-7836.2005.01461.x","article-title":"Identifying novel genetic determinants of hemostatic balance","volume":"3","author":"Ginsburg","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00335-007-9079-4","article-title":"The endothelial-specific regulatory mutation, Mvwf1, is a common mouse founder allele","volume":"19","author":"Johnsen","year":"2008","journal-title":"Mamm Genome"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0025","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1182\/blood-2006-04-014688","article-title":"Enhanced VWF biosynthesis and elevated plasma VWF due to a natural variant in the murine Vwf gene","volume":"108","author":"Lemmerhirt","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1538-7836.2007.02325.x","article-title":"Genetic regulation of plasma von Willebrand factor levels: quantitative trait loci analysis in a mouse model","volume":"5","author":"Lemmerhirt","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0035","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"Denis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0040","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1182\/blood-2008-02-142943","article-title":"Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa","volume":"112","author":"Marx","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0045","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.142005099","article-title":"Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands","volume":"99","author":"Ellies","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0050","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nm1760","article-title":"The Ashwell receptor mitigates the lethal coagulopathy of sepsis","volume":"14","author":"Grewal","year":"2008","journal-title":"Nat Med"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0055","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/01.ATV.0000259359.52265.62","article-title":"Platelet adhesion receptors and their ligands in mouse models of thrombosis","volume":"27","author":"Denis","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0060","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2006-06-028241","article-title":"von Willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0065","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI30537","article-title":"Thrombin-initiated platelet activation in vivo is vWF independent during thrombus formation in a laser injury model","volume":"117","author":"Dubois","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0070","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood.V96.10.3322","article-title":"Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins","volume":"96","author":"Andre","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s000180050487","article-title":"Insights from von Willebrand disease animal models","volume":"56","author":"Denis","year":"1999","journal-title":"Cell Mol Life Sci"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0080","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V98.5.1424","article-title":"Localized reduction of atherosclerosis in von Willebrand factor-deficient mice","volume":"98","author":"Methia","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0085","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood-2007-08-108571","article-title":"The combined roles of ADAMTS13 and VWF in murine models of TTP, endotoxemia, and thrombosis","volume":"111","author":"Chauhan","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1538-7836.2005.01770.x","article-title":"Increased metastatic potential of tumor cells in von Willebrand factor-deficient mice","volume":"4","author":"Terraube","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0095","doi-asserted-by":"crossref","first-page":"892","DOI":"10.2353\/ajpath.2008.080001","article-title":"von-Willebrand factor influences blood brain\u2013barrier permeability and brain inflammation in experimental allergic encephalomyelitis","volume":"173","author":"Noubade","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0100","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood-2008-09-180695","article-title":"Deficiency of von Willebrand factor protects mice from ischemic stroke","volume":"113","author":"Kleinschnitz","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0105","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1067\/mva.2003.63","article-title":"Overexpression of von Willebrand factor is an independent risk factor for pathogenesis of intimal hyperplasia: preliminary studies","volume":"37","author":"Qin","year":"2003","journal-title":"J Vasc Surg"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2009.03313.x","article-title":"Von Willebrand factor is a major determinant of ADAMTS-13 decrease during mouse sepsis induced by cecum ligation and puncture","author":"Lerolle","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0115","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1073\/pnas.061307098","article-title":"Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice","volume":"98","author":"Denis","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1161\/01.ATV.0000209501.56852.6c","article-title":"Dynamics and plasticity of Weibel\u2013Palade bodies in endothelial cells","volume":"26","author":"Rondaij","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V30.3.375.375","article-title":"Correction of the hemostatic defects in Von Willebrand\u2019s disease","volume":"30","author":"Perkins","year":"1967","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH07-10-0629","article-title":"Clearance of von Willebrand factor","volume":"99","author":"Denis","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0135","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1182\/blood.V97.2.465","article-title":"Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models","volume":"97","author":"Denis","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0140","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/j.1365-2516.2008.01827.x","article-title":"A phase II prospective open-label escalating dose trial of recombinant interleukin-11 in mild von Willebrand disease","volume":"14","author":"Ragni","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2009.03411.x_bb0145","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nbt1373","article-title":"Modifying murine von Willebrand factor A1 domain for in vivo assessment of human platelet therapies","volume":"26","author":"Chen","year":"2008","journal-title":"Nat Biotechnol"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2009.03411.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622174301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622174301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2009.03411.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:48:37Z","timestamp":1761533317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622174301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":28,"alternative-id":["S1538783622174301"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03411.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mouse models of von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03411.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}